Association between antiretroviral therapy adherence and employment status: Systematic review and meta-analysis;Lien entre le suivi de la thérapie antirétrovirale et le statut professionnel: Revue systématique et méta-analyse;La asociación entre la adherencia a la terapia antirretroviral y la situación laboral: Examen sistemático y metaanálisis

Bulletin of the World Health Organization

Volumn 93, Issue 1, 2015, Pages 29-41

  Nachega, Jean B ^a   Uthman, Olalekan A ^b   Peltzer, Karl ^c   Richardson, Lindsey A ^d   Mills, Edward J ^e   Amekudzi, Kofi ^f   Ouédraogo, Alice ^f  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY OF LIMPOPO   (South Africa)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f INTERNATIONAL LABOUR OFFICE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EMPLOYMENT; HEALTH CARE; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS DISEASE; SOCIOECONOMIC CONDITIONS; WORLD HEALTH ORGANIZATION;

DATA EXTRACTION; DATA SYNTHESIS; DISEASE COURSE; EMPLOYMENT STATUS; FOLLOW UP; GENDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; MEDICATION COMPLIANCE; META ANALYSIS; PUBLICATION; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SYSTEMATIC REVIEW; UNEMPLOYMENT; DEVELOPED COUNTRY; DEVELOPING COUNTRY; EMPLOYMENT; HIV INFECTIONS; STATISTICS AND NUMERICAL DATA;

HUMAN IMMUNODEFICIENCY VIRUS;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTI-HIV AGENTS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; EMPLOYMENT; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE;

EID: 84920080611     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.14.138149     Document Type: Review

References (69)

1. Global update on HIV treatment 2013: results, impact and opportunities. Geneva; World Health Organization; 2013. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2013/20130630_treatment_report_summary_en.pdf [cited 2014 Oct 17].
2. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679-90. doi: http://dx.doi.org/10.1001/jama.296.6.679 PMID: 16896111
3. Ortego C, Huedo-Medina TB, Llorca J, Sevilla L, Santos P, Rodríguez E, et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381-96. doi: http://dx.doi.org/10.1007/s10461-011-9942-x PMID: 21468660
4. Juday T, Gupta S, Grimm K, Wagner S, Kim E. Factors associated with complete adherence to HIV combination antiretroviral therapy. HIV Clin Trials. 2011;12(2):71-8. doi: http://dx.doi.org/10.1310/hct1202-71 PMID: 21498150
5. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438. doi: http://dx.doi.org/10.1371/journal.pmed.0030438 PMID: 17121449
6. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181-3. doi: http://dx.doi.org/10.1097/00002030-200106150-00015 PMID: 11416722
7. Clavel F, Hance AJ. HIV drug resistance. N Engl J Med. 2004;350(10):1023-35. doi: http://dx.doi.org/10.1056/NEJMra025195 PMID: 14999114
8. Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med. 2007;146(8):564-73. doi: http://dx.doi.org/10.7326/0003-4819-146-8-200704170-00007 PMID: 17438315
9. Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, et al. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006;43(1):78-84. doi: http://dx.doi.org/10.1097/01.qai.0000225015.43266.46 PMID: 16878045
10. Baggaley RF, White RG, Hollingsworth TD, Boily MC. Heterosexual HIV-1 infectiousness and antiretroviral use: systematic review of prospective studies of discordant couples. Epidemiology. 2013;24(1):110-21. doi: http://dx.doi.org/10.1097/EDE.0b013e318276cad7 PMID: 23222513
11. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al.; HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493-505. doi: http://dx.doi.org/10.1056/NEJMoa1105243 PMID: 21767103
12. Nachega JB, Leisegang R, Bishai D, Nguyen H, Hislop M, Cleary S, et al. Association of antiretroviral therapy adherence and health care costs. Ann Intern Med. 2010;152(1):18-25. doi: http://dx.doi.org/10.7326/0003-4819-152-1-201001050-00006 PMID: 20048268
13. Liu GG, Guo JJ, Smith SR. Economic costs to business of the HIV/AIDS epidemic. Pharmacoeconomics. 2004;22(18):1181-94. doi: http://dx.doi.org/10.2165/00019053-200422180-00003 PMID: 15606225
14. Falagas ME, Zarkadoulia EA, Pliatsika PA, Panos G. Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature. Retrovirology. 2008;5(1):13. doi: http://dx.doi.org/10.1186/1742-4690-5-13 PMID: 18241330
15. Peltzer K, Pengpid S. Socioeconomic factors in adherence to HIV therapy in low-and middle-income countries. J Health Popul Nutr. 2013;31(2):150-70. doi: http://dx.doi.org/10.3329/jhpn.v31i2.16379 PMID: 23930333
16. Atkinson MJ, Petrozzino JJ. An evidence-based review of treatment-related determinants of patients’ nonadherence to HIV medications. AIDS Patient Care STDS. 2009;23(11):903-14. doi: http://dx.doi.org/10.1089/apc.2009.0024 PMID: 19642921
17. Arrivillaga M, Ross M, Useche B, Alzate ML, Correa D. Social position, gender role, and treatment adherence among Colombian women living with HIV/AIDS: social determinants of health approach. Rev Panam Salud Publica. 2009;26(6):502-10. doi: http://dx.doi.org/10.1590/S1020-49892009001200005 PMID: 20107704
18. Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med. 2004;19(11):1111-7. doi: http://dx.doi.org/10.1111/j.1525-1497.2004.30445.x PMID: 15566440
19. Nachega JB, Uthman OA, Mills EJ, Peltzer K, Amekudzi K, Ouedraogo A. The impact of employment on HIV treatment adherence. Geneva: International Labour Organization; 2013. Available from: http://www.ilo.org/wcmsp5/groups/public/---ed_protect/---protrav/---ilo_aids/documents/publication/wcms_230625.pdf [cited 2014 Sep 21].
20. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: http://dx.doi.org/10.1371/journal.pmed.1000097 PMID: 19621072
21. Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS, Hahn S, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013;66(4):408-14. doi: http://dx.doi.org/10.1016/j.jclinepi.2012.09.016 PMID: 23337781
22. Country and Lending Groups [Internet]. Washington: World Bank; 2014. Available from: http://data.worldbank.org/about/country-and-lending-groups [cited 2014 Sep 20].
23. Current international recommendations on labour statistics. Geneva: International Labour Office; 2000.
24. Galobardes B, Shaw M, Lawlor DA, Lynch JW, Davey Smith G. Indicators of socioeconomic position (part 1). J Epidemiol Community Health. 2006;60(1):7-12. doi: http://dx.doi.org/10.1136/jech.2004.023531 PMID: 16361448
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88. doi: http://dx.doi.org/10.1016/0197-2456(86)90046-2 PMID: 3802833
26. Normand SL. Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med. 1999;18(3):321-59. doi: http://dx.doi.org/10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P PMID: 10070677
27. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996;8(3):261-9. doi: http://dx.doi.org/10.1080/09540129650125696 PMID: 8827119
28. Singh N, Berman SM, Swindells S, Justis JC, Mohr JA, Squier C, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis. 1999;29(4):824-30. doi: http://dx.doi.org/10.1086/520443 PMID: 10589897
29. Duong M, Piroth L, Grappin M, Forte F, Peytavin G, Buisson M, et al. Evaluation of the Patient Medication Adherence Questionnaire as a tool for self-reported adherence assessment in HIV-infected patients on antiretroviral regimens. HIV Clin Trials. 2001;2(2):128-35. doi: http://dx.doi.org/10.1310/M3JR-G390-LXCM-F62G PMID: 11590521
30. Ickovics JR, Cameron A, Zackin R, Bassett R, Chesney M, Johnson VA, et al.; Adult AIDS Clinical Trials Group 370 Protocol Team. Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370. Antivir Ther. 2002;7(3):185-93. PMID: 12487386
31. Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, et al. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses. 2004;20(10):1053-6. doi: http://dx.doi.org/10.1089/aid.2004.20.1053 PMID: 15585095
32. Beyene KA, Gedif T, Gebre-Mariam T, Engidawork E. Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia. Pharmacoepidemiol Drug Saf. 2009;18(11):1007-15. doi: http://dx.doi.org/10.1002/pds.1814 PMID: 19650153
33. Duggan JM, Locher A, Fink B, Okonta C, Chakraborty J. Adherence to antiretroviral therapy: a survey of factors associated with medication usage. AIDS Care. 2009;21(9):1141-7. doi: http://dx.doi.org/10.1080/09540120902730039 PMID: 20024773
34. Nakimuli-Mpungu E, Mutamba B, Othengo M, Musisi S. Psychological distress and adherence to highly active anti-retroviral therapy (HAART) in Uganda: a pilot study. Afr Health Sci. 2009;9 Suppl 1:S2-7. PMID: 20589156
35. Campos LN, Guimarães MD, Remien RH. Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS Behav. 2010;14(2):289-99. doi: http://dx.doi.org/10.1007/s10461-008-9435-8 PMID: 18648925
36. Giday A, Shiferaw W. Factors affecting adherence of antiretroviral treatment among AIDS patients in an Ethiopian tertiary university teaching hospital. Ethiop Med J. 2010;48(3):187-94. PMID: 21073079
37. Kunutsor S, Walley J, Katabira E, Muchuro S, Balidawa H, Namagala E, et al. Clinic attendance for medication refills and medication adherence amongst an antiretroviral treatment cohort in Uganda: a prospective study. Aids Res Treat. 2010;2010:872396. doi: http://dx.doi.org/10.1155/2010/872396 PMID: 21490907
38. Lal V, Kant S, Dewan R, Rai SK, Biswas A. A two-site hospital-based study on factors associated with nonadherence to highly active antiretroviral therapy. Indian J Public Health. 2010;54(4):179-83. doi: http://dx.doi.org/10.4103/0019-557X.77256 PMID: 21372363
39. Li L, Lee SJ, Wen Y, Lin C, Wan D, Jiraphongsa C. Antiretroviral therapy adherence among patients living with HIV/AIDS in Thailand. Nurs Health Sci. 2010;12(2):212-20. doi: http://dx.doi.org/10.1111/j.1442-2018.2010.00521.x PMID: 20602694
40. Peltzer K, Friend-du Preez N, Ramlagan S, Anderson J. Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa. BMC Public Health. 2010;10(1):111. doi: http://dx.doi.org/10.1186/1471-2458-10-111 PMID: 20205721
41. Sherr L, Lampe FC, Clucas C, Johnson M, Fisher M, Leake Date H, et al. Self-reported non-adherence to ART and virological outcome in a multiclinic UK study. AIDS Care. 2010;22(8):939-45. doi: http://dx.doi.org/10.1080/09540121.2010.482126 PMID: 20574863
42. Venkatesh KK, Srikrishnan AK, Mayer KH, Kumarasamy N, Raminani S, Thamburaj E, et al. Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings. AIDS Patient Care STDS. 2010;24(12):795-803. doi: http://dx.doi.org/10.1089/apc.2010.0153 PMID: 21091232
43. Harris J, Pillinger M, Fromstein D, Gomez B, Garris I, Kanetsky PA, et al. Risk factors for medication non-adherence in an HIV infected population in the Dominican Republic. AIDS Behav. 2011;15(7):1410-5. doi: http://dx.doi.org/10.1007/s10461-010-9781-1 PMID: 20721615
44. Kyser M, Buchacz K, Bush TJ, Conley LJ, Hammer J, Henry K, et al. Factors associated with non-adherence to antiretroviral therapy in the SUN study. AIDS Care. 2011;23(5):601-11. doi: http://dx.doi.org/10.1080/09540121.2010.525603 PMID: 21293992
45. Wakibi SN, Ng’ang’a ZW, Mbugua GG. Factors associated with non-adherence to highly active antiretroviral therapy in Nairobi, Kenya. AIDS Res Ther. 2011;8(1):43. doi: http://dx.doi.org/10.1186/1742-6405-8-43 PMID: 22141425
46. King RM, Vidrine DJ, Danysh HE, Fletcher FE, McCurdy S, Arduino RC, et al. Factors associated with nonadherence to antiretroviral therapy in HIV-positive smokers. AIDS Patient Care STDS. 2012;26(8):479-85. doi: http://dx.doi.org/10.1089/apc.2012.0070 PMID: 22612468
47. Kitshoff C, Campbell L, Naidoo SS. The association between depression and adherence to antiretroviral therapy in HIV-positive patients, KwaZulu-Natal, South Africa. S Afr Fam Pract. 2012;54(2):145-50. doi: http://dx.doi.org/10.1080/20786204.2012.10874194
48. Berhe N, Tegabu D, Alemayehu M. Effect of nutritional factors on adherence to antiretroviral therapy among HIV-infected adults: a case control study in Northern Ethiopia. BMC Infect Dis. 2013;13(1):233. doi: http://dx.doi.org/10.1186/1471-2334-13-233 PMID: 23701864
49. Okoronkwo I, Okeke U, Chinweuba A, Iheanacho P. Nonadherence factors and sociodemographic characteristics of HIV-infected adults receiving antiretroviral therapy in Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria. ISRN AIDS. 2013;2013:843794. doi: http://dx.doi.org/10.1155/2013/843794 PMID: 24369526
50. Vissman AT, Young AM, Wilkin AM, Rhodes SD. Correlates of HAART adherence among immigrant Latinos in the Southeastern United States. AIDS Care. 2013;25(3):356-63. PMID: 22835082
51. Tran BX, Nguyen LT, Nguyen NH, Hoang QV, Hwang J. Determinants of antiretroviral treatment adherence among HIV/AIDS patients: a multisite study. Glob Health Action. 2013;6(0):19570. doi: http://dx.doi.org/10.3402/gha.v6i0.19570 PMID: 23497956
52. Saha R, Saha I, Sarkar AP, Das DK, Misra R, Bhattacharya K, et al. Adherence to highly active antiretroviral therapy in a tertiary care hospital in West Bengal, India. Singapore Med J. 2014;55(2):92-8. doi: http://dx.doi.org/10.11622/smedj.2014021 PMID: 24570318
53. Shigdel R, Klouman E, Bhandari A, Ahmed LA. Factors associated with adherence to antiretroviral therapy in HIV-infected patients in Kathmandu District, Nepal. HIV AIDS (Auckl). 2014;6:109-16. doi: http://dx.doi.org/10.2147/HIV.S55816 PMID: 25028564
54. Johada M. Work, employment, and unemployment: values, theories, and approaches in social research. Am Psychol. 1981;36(2):184-91. doi: http://dx.doi.org/10.1037/0003-066X.36.2.184
55. Sousa-Ribeiro M, Sverke M, Coimbra L. Perceived quality of the psychosocial environment and well-being in employed and unemployed older adults: the importance of latent benefits and environmental vitamins. Econ Ind Democracy. Epub 2014 Jul 26. doi: http://dx.doi.org/10.1177/0143831X13491840
56. Murphy GC, Athanasou JA. The effect of unemployment on mental health. J Occup Organ Psychol. 1999;72(1):83-99. doi: http://dx.doi.org/10.1348/096317999166518
57. Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr. 2011;58(2):181-7. PMID: 21857529
58. Milloy MJ, Kerr T, Bangsberg DR, Buxton J, Parashar S, Guillemi S, et al. Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting. AIDS Patient Care STDS. 2012;26(1):60-7. doi: http://dx.doi.org/10.1089/apc.2011.0169 PMID: 22107040
59. Young S, Wheeler AC, McCoy SI, Weiser SD. A review of the role of food insecurity in adherence to care and treatment among adult and pediatric populations living with HIV and AIDS. AIDS Behav. 2014;18(S5) Suppl 5:505-15. doi: http://dx.doi.org/10.1007/s10461-013-0547-4 PMID: 23842717
60. Rueda S, Raboud J, Mustard C, Bayoumi A, Lavis JN, Rourke SB. Employment status is associated with both physical and mental health quality of life in people living with HIV. AIDS Care. 2011;23(4):435-43. doi: http://dx.doi.org/10.1080/09540121.2010.507952 PMID: 21271396
61. Rosen S, Ketlhapile M, Sanne I, Desilva MB. Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa. AIDS. 2008;22 Suppl 1:S131-9. doi: http://dx.doi.org/10.1097/01.aids.0000327634.92844.91 PMID: 18664945
62. Bor J, Tanser F, Newell ML, Bärnighausen T. In a study of a population cohort in South Africa, HIV patients on antiretrovirals had nearly full recovery of employment. Health Aff (Millwood). 2012;31(7):1459-69. doi: http://dx.doi.org/10.1377/hlthaff.2012.0407 PMID: 22778335
63. Dahab M, Kielmann K, Charalambous S, Karstaedt AS, Hamilton R, La Grange L, et al. Contrasting reasons for discontinuation of antiretroviral therapy in workplace and public-sector HIV programs in South Africa. AIDS Patient Care STDS. 2011;25(1):53-9. doi: http://dx.doi.org/10.1089/apc.2010.0140 PMID: 21214378
64. Braitstein P, Boulle A, Nash D, Brinkhof MW, Dabis F, Laurent C, et al.; Antiretroviral Therapy in Lower Income Countries (ART-LINC) study group. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health (Larchmt). 2008;17(1):47-55. doi: http://dx.doi.org/10.1089/jwh.2007.0353 PMID: 18240981
65. Anema A, Vogenthaler N, Frongillo EA, Kadiyala S, Weiser SD. Food insecurity and HIV/AIDS: current knowledge, gaps, and research priorities. Curr HIV/AIDS Rep. 2009;6(4):224-31. doi: http://dx.doi.org/10.1007/s11904-009-0030-z PMID: 19849966
66. Puskas CM, Forrest JI, Parashar S, Salters KA, Cescon AM, Kaida A, et al. Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011. Curr HIV/AIDS Rep. 2011;8(4):277-87. doi: http://dx.doi.org/10.1007/s11904-011-0098-0 PMID: 21989672
67. Nachega JB, Mugavero MJ, Zeier M, Vitória M, Gallant JE. Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs. Patient Prefer Adherence. 2011;5:357-67. doi: http://dx.doi.org/10.2147/PPA.S22771 PMID: 21845035
68. Nachega JB, Parienti JJ, Uthman OA, Gross R, Dowdy DW, Sax PE, et al. Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: a meta-analysis of randomized controlled trials. Clin Infect Dis. 2014;58(9):1297-307. doi: http://dx.doi.org/10.1093/cid/ciu046 PMID: 24457345
69. Ioannidis JP, Patsopoulos NA, Rothstein HR. Reasons or excuses for avoiding meta-analysis in forest plots. BMJ. 2008;336(7658):1413-5. doi: http://dx.doi.org/10.1136/bmj.a117 PMID: 18566080